BMRA

BIOMERICA INC

1.61

USD

0.00

0.00%

Nov 06, 15:36 UTC -5

Closed

Pre-Market

1.60

-0.01

-0.31%

BIOMERICA INC (BMRA) Earnings

BMRA Earnings Reports

Positive Surprise Ratio

BMRA beat 10 of 18 last estimates.

56%

Next Report

Date of Next Report

Jan 12, 2027

Estimate for Q2 27 (Revenue/ EPS)

Implied change from Q1 27 (Revenue/ EPS)

Implied change from Q2 26 (Revenue/ EPS)

BIOMERICA INC earnings per share and revenue

On Oct 12, 2026, BMRA reported earnings of -- USD per share (EPS) for Q1 27, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q2 27, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Aldeyra Therapeutics, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.09

Actual

-$0.06

Surprise

+37.43%

Lipocine Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.36

Actual

-$0.08

Surprise

+77.91%

Ernexa Therapeutics Inc. Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$3.91

Actual

-$1.89

Surprise

+51.75%

ZOETIS INC.

Report Date

Nov 05, 2026 For Q3 26

Estimate

$1.52

Actual

$1.75

Surprise

+14.64%

Dyne Therapeutics, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.92

Actual

-$1.06

Surprise

-15.57%

Amylyx Pharmaceuticals, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.38

Actual

-$0.38

Surprise

+1.04%

Cronos Group Inc. Common Share

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.03

Actual

$0.04

Surprise

+17.65%

Aclaris Therapeutics, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.16

Actual

-$0.12

Surprise

+28.49%

Protara Therapeutics, Inc. Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.37

Actual

-$0.35

Surprise

+6.17%

Minerva Neurosciences, Inc

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.12

Actual

$1.94

Surprise

+1,629.97%

FAQ

What were BIOMERICA INC's earnings and revenue for the latest quarter Q1 2027?

For Q1 2027, BIOMERICA INC reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to BIOMERICA INC's Q1 2027 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is BIOMERICA INC expected to report next?

The next earning report is scheduled for Jan 12, 2027.

What are the forecasts for BIOMERICA INC's next earnings report?

Based on -- analysts, BIOMERICA INC is expected to report EPS of -- and revenue of -- for Q2 2027.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.